Eculizumab Therapy for Chronic Antibody-Mediated Injury in Kidney Transplant Recipients: A Pilot Randomized Controlled Trial

American Journal of Transplantation- United Kingdom

doi 10.1111/ajt.14001

Full Text

Abstract

Available in

Date

Authors

Publisher

Wiley

Related search

A Pilot Randomized Controlled Trial to Promote Immunosuppressant Adherence in Adult Kidney Transplant Recipients

Nephron
MedicineUrologyPhysiologyNephrology
2016English

Successful Salvage Treatment of Resistant Acute Antibody-Mediated Kidney Transplant Rejection With Eculizumab

Sultan Qaboos University Medical Journal
Medicine
2016English

Photodynamic Therapy Is More Effective Than Imiquimod for Actinic Keratosis in Organ Transplant Recipients - A Randomized Intra-Individual Controlled Trial

British Journal of Dermatology
DermatologyMedicine
2018English

Erythropoietin in Traumatic Brain Injury Associated Acute Kidney Injury: A Randomized Controlled Trial

Acta Anaesthesiologica Scandinavica
MedicineAnesthesiologyPain Medicine
2018English

Improving Outcomes of Renal Transplant Recipients With Behavioral Adherence Contracts: A Randomized Controlled Trial

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2013English

Cognitive Behavior Therapy for Chronic Fatigue Syndrome: A Randomized Controlled Trial

American Journal of Psychiatry
PsychiatryMental Health
1997English

Cognitive Symptom Management and Rehabilitation Therapy (CogSMART) for Veterans With Traumatic Brain Injury: Pilot Randomized Controlled Trial

Journal of Rehabilitation Research and Development
Rehabilitation
2014English

Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients: A Single-Center Experience With a Bortezomib-Based Regimen

Experimental and Clinical Transplantation
Transplantation
2012English

Nonsurgical Periodontal Therapy in CKD: Findings of the Kidney and Periodontal Disease (KAPD) Pilot Randomized Controlled Trial

Kidney Medicine
Internal MedicineNephrology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy